Phase 1 Clinical Trials: Challenges and Opportunities in Latin America.
作者信息
Nardo Mirella, Xavier Camila Bragança, Franke Fabio
机构信息
Department of Clinical Oncology, ICESP - Instituto do Câncer do Estado de São Paulo, São Paulo, SP, Brazil.
Department of Clinical Oncology, Hospital Sirio-Libanês, São Paulo, SP, Brazil.
出版信息
J Immunother Precis Oncol. 2024 Aug 19;7(3):168-170. doi: 10.36401/JIPO-23-42. eCollection 2024 Aug.
Abstract
摘要
相似文献
1
Phase 1 Clinical Trials: Challenges and Opportunities in Latin America.
J Immunother Precis Oncol. 2024 Aug 19;7(3):168-170. doi: 10.36401/JIPO-23-42. eCollection 2024 Aug.
2
Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities.
Oncologist. 2019 Aug;24(8):e709-e719. doi: 10.1634/theoncologist.2018-0318. Epub 2019 Mar 25.
3
How to become a pediatric neurosurgeon in Latin America: training opportunities, current status, and future challenges.
Childs Nerv Syst. 2023 Jun;39(6):1627-1633. doi: 10.1007/s00381-023-05882-8. Epub 2023 Mar 11.
4
Building Capacity and Training for Digital Health: Challenges and Opportunities in Latin America.
J Med Internet Res. 2019 Dec 18;21(12):e16513. doi: 10.2196/16513.
5
Opportunities and challenges for clinical and cardiovascular research in Latin America.
Am J Ther. 2006 Jul-Aug;13(4):309-14. doi: 10.1097/00045391-200607000-00006.
6
Challenges and opportunities in NMIBC management across Latin America: insights from healthcare providers and a patient advocacy group.
Ecancermedicalscience. 2024 Jun 7;18:1711. doi: 10.3332/ecancer.2024.1711. eCollection 2024.
7
Challenges in the Management of Psoriatic Arthritis in Latin America: A Systematic Review.
Clin Ther. 2023 Sep;45(9):860-867. doi: 10.1016/j.clinthera.2023.04.005. Epub 2023 May 15.
8
Perspectives on brain health and dementia prevention in Latin America: challenges and opportunities.
Front Dement. 2023 Oct 16;2:1275641. doi: 10.3389/frdem.2023.1275641. eCollection 2023.
9
A research agenda to guide progress on childhood obesity prevention in Latin America.
Obes Rev. 2017 Jul;18 Suppl 2(Suppl 2):19-27. doi: 10.1111/obr.12572.
10
Capacity for childhood obesity research in Latin American and US Latino populations: State of the field, challenges, opportunities, and future directions.
Obes Rev. 2021 Jun;22 Suppl 3(Suppl 3):e13244. doi: 10.1111/obr.13244. Epub 2021 Apr 6.
引用本文的文献
1
Constructing the cure: engineering the next wave of antibody and cellular immune therapies.
J Immunother Cancer. 2025 Aug 25;13(8):e011761. doi: 10.1136/jitc-2025-011761.
本文引用的文献
1
Socioeconomic Impact of Cancer in Latin America and The Caribbean.
Arch Med Res. 2022 Dec;53(8):818-825. doi: 10.1016/j.arcmed.2022.11.013. Epub 2022 Nov 29.
2
An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean.
Lancet Reg Health Am. 2022 Sep;13:None. doi: 10.1016/j.lana.2022.100294.
3
Race/ethnicity reporting and representation in US clinical trials: a cohort study.
Lancet Reg Health Am. 2022 Jul;11. doi: 10.1016/j.lana.2022.100252. Epub 2022 Apr 10.
4
Success and failure factors of patient recruitment for industry-sponsored clinical trials and the role of the electronic health records-a qualitative interview study in the Nordic countries.
Trials. 2022 May 12;23(1):385. doi: 10.1186/s13063-022-06144-9.
5
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward.
Lancet Oncol. 2021 Nov;22(11):e474-e487. doi: 10.1016/S1470-2045(21)00492-7.
6
Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries.
J Oncol. 2018 Jul 2;2018:8092702. doi: 10.1155/2018/8092702. eCollection 2018.
7
Barriers for conducting clinical trials in developing countries- a systematic review.
Int J Equity Health. 2018 Mar 22;17(1):37. doi: 10.1186/s12939-018-0748-6.
8
Exploring Data Quality Management within Clinical Trials.
Appl Clin Inform. 2018 Jan;9(1):72-81. doi: 10.1055/s-0037-1621702. Epub 2018 Jan 31.
9
Regulatory challenges associated with conducting multicountry clinical trials in resource-limited settings.
J Acquir Immune Defic Syndr. 2014 Jan 1;65 Suppl 1(0 1):S29-31. doi: 10.1097/QAI.0000000000000037.
10
The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries.
BMC Public Health. 2011 Oct 18;11:811. doi: 10.1186/1471-2458-11-811.
Zotero 插件